Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial

BACKGROUND: ADVANCE (NCT01304836) was a phase 4, multicenter, prospectively randomized, open-label, 24-week study comparing the incidence of posttransplantation diabetes mellitus (PTDM) with 2 prolonged-release tacrolimus corticosteroid minimization regimens. METHODS: All patients received prolonged...

Descripción completa

Detalles Bibliográficos
Autores principales: Mourad, Georges, Glyda, Maciej, Albano, Laetitia, Viklický, Ondrej, Merville, Pierre, Tydén, Gunnar, Mourad, Michel, Lõhmus, Aleksander, Witzke, Oliver, Christiaans, Maarten H. L., Brown, Malcolm W., Undre, Nasrullah, Kazeem, Gbenga, Kuypers, Dirk R. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Original Clinical Science—General
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542786/
https://www.ncbi.nlm.nih.gov/pubmed/27547871
http://dx.doi.org/10.1097/TP.0000000000001453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542786/
https://www.ncbi.nlm.nih.gov/pubmed/27547871
http://dx.doi.org/10.1097/TP.0000000000001453

Ejemplares similares